Angiotensin receptor blocker versus angiotensin receptor-neprilysin inhibitor in improved HF with stabilized NT-proBNP levels [0.03%]
ARNI与ARB用于ACEI转换后HF患者稳定期NT-proBNP水平治疗效应的比较研究
Minjung Bak,Yoonjee Park,Darae Kim et al.
Minjung Bak et al.
Introduction and objectives: The management of heart failure with improved ejection fraction remains unresolved, particularly after stabilization. This study aimed to determine whether maintenance with an angiotensin rece...
Pulmonary artery growth in Fontan: what is the most effective strategy? [0.03%]
Fontan手术后肺动脉发育情况：哪种策略最有效？
Neil Derridj,Manon Hily,Olivier Raisky et al.
Neil Derridj et al.
Prognostic significance of combined pulmonary hypertension in mitral regurgitation surgery [0.03%]
二尖瓣反流手术中联合肺动脉高压的预后意义
Néstor Báez-Ferrer,Marc Abril-Pla,Anas Waleed Al-Hayani-Al-Hantoosh et al.
Néstor Báez-Ferrer et al.
FLNC mutation associated with sudden cardiac death in the absence of structural heart disease [0.03%]
无结构性心脏病突发性心脏死亡与FLNC基因突变的关系
Diego Andrés Isa Sáez,Rodrigo Andrés Isa Param
Diego Andrés Isa Sáez
Impact of P2Y12 inhibitor pretreatment on periprocedural (type 4a) myocardial infarction and bleeding in NSTEMI [0.03%]
P2Y12抑制剂预处理对非ST段抬高型心肌梗死患者经皮冠状动脉介入术围手术期(类型4a)心肌梗死和出血的影响
Matteo Armillotta,Francesca Bodega,Luca Bergamaschi et al.
Matteo Armillotta et al.
Introduction and objectives: Although widely used in clinical practice, pretreatment with a P2Y12 inhibitor in patients with non-ST-segment elevation myocardial infarction (NSTEMI) remains controversial and is not recomme...
Intravascular imaging-guided percutaneous coronary intervention for acute myocardial infarction according to ACC/AHA lesion classification [0.03%]
根据ACC / AHA病变分类，采用血管内成像指导急性心肌梗死经皮冠状动脉介入治疗
Sang Yoon Lee,Hyun Sung Joh,Hyun Kuk Kim et al.
Sang Yoon Lee et al.
Introduction and objectives: Despite the favorable prognosis associated with intravascular imaging (IVI)-guided percutaneous coronary intervention (PCI) for complex coronary lesions, it is still unclear whether IVI-guided...
Correction in article by Molina-Lerma et al. "Spanish pacemaker registry. 21st official report of Heart Rhythm Association of the Spanish Society of Cardiology (2023)", Rev Esp Cardiol. 2024;77:947-956 [0.03%]
对 Molina-Lerma 等人撰写的文章《西班牙起搏器登记。西班牙心脏病学会心律协会第 21 届官方报告（2023 年）》的更正，Rev Esp Cardiol. 2024;77:947-956
Impact of dapagliflozin on key pathophysiological pathways underlying chronic heart failure progression: the DAPA-MODA biomarker study [0.03%]
达格列净对慢性心力衰竭进展的关键病理生理途径的影响：DAPA-MODA生物标志物研究
Verónica Martínez-Pina,Antoni Bayés Genís,Julio Nuñez et al.
Verónica Martínez-Pina et al.
Introduction and objectives: Dapagliflozin improves clinical outcomes in patients with chronic heart failure (HF), irrespective of left ventricular ejection fraction. However, its effects on circulating biomarkers that re...
Transcatheter closure of ostium secundum atrial septal defects: echocardiogram predictors of device embolization [0.03%]
封堵器封堵继发孔型房间隔缺损的超声心动图预测因素及伞栓的预测因子
Grégoire Albenque,Estibaliz Valdeolmillos,Marine Cachanado et al.
Grégoire Albenque et al.